- Home
- OBIO vs MHF Comparison
OBIO vs MHF Comparison
Compare OBIO & MHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- MHF
- Stock Information
- Founded
- OBIO 2017
- MHF 1988
- Country
- OBIO United States
- MHF United States
- Employees
- OBIO N/A
- MHF N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- MHF Finance/Investors Services
- Sector
- OBIO Health Care
- MHF Finance
- Exchange
- OBIO Nasdaq
- MHF Nasdaq
- Market Cap
- OBIO 172.1M
- MHF 152.9M
- IPO Year
- OBIO N/A
- MHF N/A
- Fundamental
- Price
- OBIO $4.24
- MHF $7.02
- Analyst Decision
- OBIO Strong Buy
- MHF
- Analyst Count
- OBIO 4
- MHF 0
- Target Price
- OBIO $13.67
- MHF N/A
- AVG Volume (30 Days)
- OBIO 301.5K
- MHF 57.2K
- Earning Date
- OBIO 11-10-2025
- MHF 01-01-0001
- Dividend Yield
- OBIO N/A
- MHF 4.29%
- EPS Growth
- OBIO N/A
- MHF N/A
- EPS
- OBIO N/A
- MHF N/A
- Revenue
- OBIO $2,818,000.00
- MHF N/A
- Revenue This Year
- OBIO $31.43
- MHF N/A
- Revenue Next Year
- OBIO $10.87
- MHF N/A
- P/E Ratio
- OBIO N/A
- MHF N/A
- Revenue Growth
- OBIO 6.46
- MHF N/A
- 52 Week Low
- OBIO $2.20
- MHF $5.92
- 52 Week High
- OBIO $6.30
- MHF $6.79
- Technical
- Relative Strength Index (RSI)
- OBIO 63.87
- MHF 46.57
- Support Level
- OBIO $3.86
- MHF $6.87
- Resistance Level
- OBIO $4.02
- MHF $7.11
- Average True Range (ATR)
- OBIO 0.30
- MHF 0.09
- MACD
- OBIO 0.00
- MHF 0.01
- Stochastic Oscillator
- OBIO 89.22
- MHF 45.16
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About MHF Western Asset Municipal High Income Fund Inc.
Western Asset Municipal High Income Fund Inc is a diversified closed-end management investment company. The company's objective is to seek high current income exempt from federal income taxes. It invests predominantly in intermediate and long-term municipal debt securities issued by state and local governments.